Premium research-grade CJC-1295 (also known as Modified GRF 1-29) supplied as a lyophilized compound for laboratory research use by qualified professionals. For laboratory research use only. Not for human or animal use.
Classification: Synthetic analog of endogenous Growth Hormone-Releasing Hormone (GHRH); specifically a tetrasubstituted peptide fragment consisting of amino acids 1–29.
Technical Specifications:
Research Context: CJC-1295 without DAC is utilized in preclinical research to study the pulsatile release of endogenous growth hormone. Unlike its DAC-conjugated counterpart, this variant is investigated for its shorter half-life (~30 minutes), making it a candidate for research models focusing on acute hormonal signaling and natural secretory rhythms. Research focus is typically placed on its interaction with the GHRH receptors in the pituitary and its subsequent influence on IGF-1 levels, lipid metabolism, and protein synthesis in various experimental systems.
